Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept

Pediatr Infect Dis J. 2003 Mar;22(3):286-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents
  • Arthritis, Infectious / complications
  • Arthritis, Infectious / drug therapy
  • Arthritis, Infectious / etiology*
  • Arthritis, Juvenile / diagnosis
  • Arthritis, Juvenile / drug therapy*
  • Child
  • Combined Modality Therapy
  • Drainage / methods
  • Drug Therapy, Combination / administration & dosage
  • Etanercept
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Magnetic Resonance Imaging
  • Osteomyelitis / complications
  • Osteomyelitis / etiology*
  • Osteomyelitis / therapy
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Risk Assessment
  • Streptococcal Infections / diagnosis*
  • Streptococcal Infections / drug therapy
  • Streptococcus pyogenes / drug effects
  • Streptococcus pyogenes / isolation & purification*
  • Toes
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Etanercept